TOP POSTER Recurrent Multiple Lipomas in a Patient with Bilateral Retinoblastoma: A Rare Genetic Association Tamara Fakhoury, DO; Armaan Guraya, DO; Joseph Kamel, DO; Stephanie Martin, MD
TOP POSTER Association Between Palmoplantar Pustulosis and Pulmonary Disease: A Nested Case-control Study of the All of Us Database Olivia Kam BA; Sara Osborne BS; Shivani Thacker D.O.; Carolynne Vo BS; Raquel Wescott BS; Jashin J. Wu M.D.
TOP POSTER Improving Medical Student Education in Skin of Color Dahyeon Kim B.S., Akosua Sarfo B.S., Lori Horhor B.S., Rebekah Leigh M.D., Meera Ricci M.D., Janiene Luke M.D.
TOP POSTER Oral Tranexamic Acid for the Treatment of Melasma in Patients of Color: A Systematic Literature Review Carolynne Vo, B.S., Arambi Eyong, B.S., Ardalan Minokadeh, M.D., Ph.D
TOP POSTER An Evidence-based Review on the Treatment of Hidradenitis Suppurativa With Glucagon-like Peptide 1 Receptor Agonists Seanna Yang, B.S., Minka Gill, B.S., Dahyeon Kim, B.S., Nickoulet Babaei, B.S., Mireya Cervantes, B.S., Jashin J. Wu, M.D.
TOP POSTER Utility of ENLIST Severity Scale For Erythema Nodosum leprosum: A Clinically-Supported Critical Appraisal Heather M. Zimmerman BSN, Ralina Karagenova MS, Joshua D. Seid BS, Sarini Saksena BS, Bao Xin Liang BS, Braden Yoshinaga BS, Tony Head BS, David J. Elpern MD and Douglas W. Johnson MD
VISIBLE: Efficacy of Guselkumab at Week 16 in Moderate-to-Severe Scalp Psoriasis Participants with Low Body Surface Area Involvement Lorne Albrecht MD; Mona Shahriari MD; Stephen Tyring MD, PhD; Angela Moore MD; Stacy Smith MD; Charles Lynde MD; Kush Shah PhD; Theo Alkousakis MD; Olivia Choi MD, PhD; Katelyn Rowland MS, ARNP; Daphne Chan PhD; Jenny Jeyarajah PhD; Oscar Salgado Barrero
Deucravacitinib in plaque psoriasis: 4-year safety and efficacy results from the phase 3 POETYK PSO-1, PSO-2, and LTE trials April W. Armstrong, Mark Lebwohl, Richard B. Warren, Howard Sofen, Akimichi Morita, Shinichi Imafuku, Mamitaro Ohtsuki, Lynda Spelman, Thierry Passeron, Kim A. Papp, Matthew J. Colombo, John Vaile, Eleni Vritzali, Kim Hoyt, Carolin Daamen, Subhashis Banerjee,Bruce Strober, Diamant Thaçi, Andrew Blauvelt
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor in scalp psoriasis: design of a phase 3b/4, multicenter, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety in patients with moderate to severe scalp psoriasis Kristina Callis Duffin, Andrew Blauvelt, Eugene Balagula, Rachel Dyme, Virginia Hala, Kim Hoyt, Christopher E.M. Griffiths, Mark Lebwohl
A Phase 2b, Long-term Extension, Dose-ranging Study of Oral JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis: FRONTIER 2 Laura K. Ferris MD, PhD; Jerry Bagel MD, MS; Yu-Huei Huang MD; Andrew Pink PhD; Stephen K. Tyring MD, PhD; Georgios Kokolakis MD; Amy M. DeLozier PhD; Shu Li PhD; Yaung-Kaung Shen PhD; Oscar Salgado Barrero PhD; Takayuki Ota MD; Robert Bissonnette MD
Response to baricitinib treatment across racial and ethnic groups in patients with alopecia areata: a retrospective analysis of 68 patients at a single institution Nina Modanlo, MHS; Carolyn Goh, MD
Use of Systemic Therapies for Vulvar Lichen Sclerosus and Vulvovaginal Lichen Planus: A Survey Study of Dermatologists and Gynecologists Celeste Richardson, BS, Alexa Kassels, BS, Ashley Elsensohn MD MPH, Olushola L. Akinshemoyin Vaughn MD, Christina Kraus MD
Majocchi’s Granuloma with Multibacterial Superimposed Infection in a Pediatric Patient Jennifer Roux (BS), Konnor Davis (BS), Evelyn Herrera (DO), Grace Kim (MD), Shuang An Liang (MD), Kira Molas-Torreblanca (DO)
TikTok Trends in Dermatology and Their Clinical Evidence Derya Turk (BS), Rajaa Shoukfeh (BS), Dilara Turk (MD), Taylor Adlam (MD), Geoffrey Potts (MD)